首页> 美国卫生研究院文献>International Journal of Nanomedicine >Preparation characterization and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles
【2h】

Preparation characterization and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles

机译:丹参酮IIA固体分散体与二氧化硅纳米粒子的制备表征和体内评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We prepared solid dispersions (SDs) of tanshinone IIA (TSIIA) with silica nanoparticles, which function as dispersing carriers, using a spray-drying method and evaluated their in vitro dissolution and in vivo performance. The extent of TSIIA dissolution in the silica nanoparticles/TSIIA system (weight ratio, 5:1) was approximately 92% higher than that of the pure drug after 60 minutes. However, increasing the content of silica nanoparticles from 5:1 to 7:1 in this system did not significantly increase the rate or extent of TSIIA dissolution. The physicochemical properties of SDs were investigated using scanning electron microscopy, differential scanning calorimetry, X-ray powder diffraction, and Fourier transforms infrared spectroscopy. Studying the stability of the SDs of TSIIA revealed that the drug content of the formulation and dissolution behavior was unchanged under the applied storage conditions. In vivo tests showed that SDs of the silica nanoparticles/TSIIA had a significantly larger area under the concentration-time curve, which was 1.27 times more than that of TSIIA (P < 0.01). Additionally, the values of maximum plasma concentration and the time to reach maximum plasma concentration of the SDs were higher than those of TSIIA and the physical mixing system. Based on these results, we conclude that the silica nanoparticle based SDs achieved complete dissolution, increased absorption rate, maintained drug stability, and showed improved oral bioavailability compared to TSIIA alone.
机译:我们使用喷雾干燥法制备了具有作为分散载体的二氧化硅纳米颗粒的丹参酮IIA(TSIIA)固体分散体(SDs),并评估了它们的体外溶出度和体内性能。 60分钟后,TSIIA在二氧化硅纳米颗粒/ TSIIA系统中的溶解程度(重量比,5:1)比纯药物的溶解程度高约92%。然而,在该系统中将二氧化硅纳米颗粒的含量从5:1增加到7:1并没有显着增加TSIIA溶解的速率或程度。使用扫描电子显微镜,差示扫描量热法,X射线粉末衍射和傅里叶变换红外光谱法研究了SD的理化性质。对TSIAA SDs稳定性的研究表明,在所应用的储存条件下,制剂中的药物含量和溶解行为没有变化。体内试验表明,在浓度-时间曲线下,二氧化硅纳米颗粒/ TSIIA的SD面积明显更大,是TSIIA的1.27倍(P <0.01)。此外,SD的最大血浆浓度值和达到最大血浆浓度的时间值高于TSIIA和物理混合系统的值。基于这些结果,我们得出的结论是,与单独的TSIIA相比,基于二氧化硅纳米颗粒的SD可以实现完全溶解,增加吸收率,保持药物稳定性并显示出更高的口服生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号